Q4 2024 Management View CEO David Brown highlighted record performance metrics, including $1.45 adjusted earnings per diluted share for the quarter, up 26% year-over-year. Total client assets reached ...

We recently compiled a list of the Why These 15 Bank Stocks Are Skyrocketing So Far In 2025. In this article, we are going to ...

Most Wall Street equity researchers still believe that AVGO stock has room to grow, despite shifting circumstances in the ...

Iterum Therapeutics PLC (NASDAQ:ITRM) reported its fourth-quarter 2024 financial results, revealing a narrower-than-expected loss. The company posted an actual EPS of -0.12, beating the forecasted EPS ...